US is buying 5 billion dollars of Pfizer COVID pills (10 million dollars of Vitamin D might do as well)
Update Nov 27, 2021: Molnupiravir only reduces risk by 30%, not 50%
New data shows Merck’s experimental covid-19 pill is less effective than early results predicted
- "But according to the latest findings Merck presented to the FDA, the pill reduced the risk of hospitalization and death only by 30 percent."
The U.S. plans to buy enough of Pfizer’s Covid antiviral pills for 10 million people
New York Times - Nov 16, 2021
30 pills to be taken within 5 days of the first sign of COVID-19 symptoms_
"The Biden administration is planning to pay more than five billion dollars for a stockpile of Pfizer’s new Covid-19 pill, enough for about 10 million courses of treatment , after the company gears up production next year, according to people familiar with the agreement."
The government has also ordered 3.1 million treatment courses, with options for 2 million more, of Merck’s pill, at about $700 per person.
PFizer Press Release Nov 7, 2021
Outcome of 1 COVID-19 paxlovid study 85% reduction in hospitalization
- summary of Press Release from c19early.com/
VitaminDWiki: Vitamin D and COVID
4 Vitamin D pills (200,000 IU might result in a similar benefit ar far less cost
Approximately 20 doses per $20 bottle = $1 per dose
So, 10 million doses = $10 million
If suspect COVID-19, take emergency Vitamin D under construction
A few of the peer-reviewed Vitamin D - COVID studies
Fight COVID-19 without drugs or vaccines, Vitamin D is the single most-studied way – Nov 2020
COVID-19 risk reduced by vitamin D supplementation – umbrella review of 7 meta-analysis – Oct 2021
French recommended 200,000 IU of Vitamin D to stop COVID-19 - Jan 2021
COVID-19 mortality extrapolates to zero at 50 ng of vitamin D – 18th Meta-analysis Sept 2021
Influenza prevented by 40 ng levels or treated with vitamin D hammer (50,000 IU) – June 2015
- Vitamin D-hammer option to flatten the COVID-19 curve - July 22, 2021 not peer reviewed
Vitamin D was a top COVID-19 treatment at 4 hospital groups - May 2021
Influence of Vitamin D on COVID-19 (Guidebook) - Benskin Sept 2021
COVID-19 mortality extrapolates to zero at 50 ng of vitamin D – 18th Meta-analysis Sept 2021
{include}
Early Treatment Options Compared
| Vitamin D >100 companies |
Molnupiravir Merck - patented |
Paxlovid Pfizer - patented |
|
| Cost per treatment | $1 | $700 | <$700 |
| Experience with medication |
>100,000,000 people over 70 years |
400 people in an RCT over a few months |
1200 people 1 month |
| COVID studies of the treatment |
>100 peer reviewed | no peer review | Press Release |
| Reduced risk of hospitalization |
>2X perhaps 8X | 2X | 6X |
| Vaccinated? | does not matter | trial participants were UNvaccinated |
trial participants were UNvaccinated |
| Health problems Treated |
COVID-19, colds, flu coronavirus, +64 others |
COVID-19 | COVID-19 |
| Health problems Prevented |
with periodic dosing 26 health problems |
none | none |